Satsuma Pharmaceuticals, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Satsuma Pharmaceuticals, Inc. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $958.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-28.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2023-03-28
- Satsuma Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $958.00K, a 349.77% increase from fiscal 2021.
- Satsuma Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $213.00K, a 166.25% increase from fiscal 2020.
- Satsuma Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2020 was $80.00K, a 59.18% decline from fiscal 2019.
- Satsuma Pharmaceuticals, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2019 was $196.00K, a 46.27% increase from fiscal 2018.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2022-12-31 | $958.00K 10-K · filed 2023-03-28 |
| 2021-12-31 | $213.00K 10-K · filed 2023-03-28 |
| 2020-12-31 | $80.00K 10-K · filed 2022-03-15 |
| 2019-12-31 | $196.00K 10-K · filed 2021-03-25 |
| 2018-12-31 | $134.00K 10-K · filed 2020-03-10 |
| 2017-12-31 | $23.00K 10-K · filed 2020-03-10 |